A short while ago, I presented a session on ‘Solving the Patient Recruitment Conundrum’ to the New Jersey Chapter of the Association of Clinical Research Professionals.

In it, I outlined the way things typically work now – with a CRO identifying research sites that may have a relevant patient population to fit the criteria for the trial.

Unfortunately, as we all know, on many occasions this simply results in the trial not recruiting in the desired timeline, so a Rescue approach is often adopted to get things back on track.

I then outlined the measures that are often taken at that stage – including such things as expanding the number of research sites, bringing in a patient recruitment agency, reaching out to doctors and patient groups etc.

One point I tried to get across was that all this additional activity could actually have been implemented much earlier – ideally even at the stage of trial design – thus avoiding any delays with recruitment in the first place.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...